生物模拟细胞膜层用于检测胰岛素和葡萄糖
Ponnusamy Nandhakumar1, Lei Sun1, Zhengxing Li1
1Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San Diego, La Jolla, California 92093, United States.
Analytical chemistry
|December 2, 2024
概括
这项研究引入了一种新的,无化学物质的生物传感器,使用HepG2细胞膜同时检测胰岛素和葡萄糖,改善糖尿病管理. 生物仿真方法提供了快速,敏感的血糖监测.
科学领域:
- 生物医学工程 生物医学工程
- 生物化学 生物化学
- 分析化学 分析化学
背景情况:
- 有效的血糖管理需要准确和快速监测胰岛素和葡萄糖水平.
- 现有的生物传感平台通常涉及复杂的表面修饰和分析物特定的捕获抗体.
- 对于糖尿病管理的简化,灵敏和同时检测方法的需求越来越大.
研究的目的:
- 开发一种新的,无化学物质的生物模拟分子识别层,用于同时检测胰岛素和葡萄糖.
- 为了利用本地细胞膜受体来简化生物传感平台.
- 展示这种新策略在分散式糖尿病监测方面的潜力.
主要方法:
- 利用HepG2细胞膜作为胰岛素和葡萄糖的自然生物仿真识别层.
- 采用简单的滴技术,将细胞膜固定在电化学传感器上.
- 通过酶标记的抗体结合来调查受体存在,并证明多重复合能力.
主要成果:
- 使用HepG2细胞膜成功构建了一个无化学物质的仿生识别层.
- 证明了同时捕获和检测胰岛素和葡萄糖.
- 在分散的条件下实现了高度敏感的胰岛素和葡萄糖的同时检测.
结论:
- 开发的生物仿真传感策略提供了一种简单,快速和高度敏感的方法,用于同时检测胰岛素和葡萄糖.
- 这种方法对改善糖尿病管理和开发各种诊断平台具有重大前景.
- 使用本地细胞膜受体消除了对长时间表面修饰和特定捕获抗体的需求.
相关概念视频
Insulin Secretory Vesicles
4.8K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.8K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.1K
Insulin: Biosynthesis, Chemistry, and Preparation
357
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
357
Insulin: The Receptor and Signaling Pathways
1.1K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.1K
Hormones Regulating Blood Glucose
3.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.1K
Glucagon-like Receptor Agonists
298
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
298


